Advances in vaccine development and the immune response against toxoplasmosis in sheep and goats
- PMID: 36090161
- PMCID: PMC9453163
- DOI: 10.3389/fvets.2022.951584
Advances in vaccine development and the immune response against toxoplasmosis in sheep and goats
Abstract
Toxoplasmosis is a zoonotic, parasitic infection caused by the intracellular, apicomplexan parasite Toxoplasma gondii, which infects all homeothermic animals including humans. The parasite has a major economic impact on the livestock industry. This is especially true for small ruminants (sheep, goats) as it is one of the most likely reasons for reproductive disorders in these animals. Primary infection in sheep and goats can result in a fetus that is mummified or macerated, fetal embryonic death, abortion, stillbirth, or the postnatal death of neonates, all of which threaten sheep and goat rearing globally. Humans can also become infected by ingesting bradyzoite-containing chevon or mutton, or the contaminated milk of sheep or goats, highlighting the zoonotic significance of this parasite. This article reviews the advances in vaccine development over recent decades and our current understanding of the immune response to toxoplasmosis in small ruminants (sheep, and goats).
Keywords: T. gondii; immune response; small ruminants; toxoplasmosis; vaccine.
Copyright © 2022 Hasan and Nishikawa.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances.Vet Res. 1998 May-Aug;29(3-4):289-310. Vet Res. 1998. PMID: 9689743 Review.
-
Global prevalence of Toxoplasma gondii infection in the aborted fetuses and ruminants that had an abortion: A systematic review and meta-analysis.Vet Parasitol. 2021 Feb;290:109370. doi: 10.1016/j.vetpar.2021.109370. Epub 2021 Jan 27. Vet Parasitol. 2021. PMID: 33550003
-
Biotechnological Based Recombinant Protein Vaccines Developed Against Toxoplasmosis.Turkiye Parazitol Derg. 2022 Nov 28;46(4):342-357. doi: 10.4274/tpd.galenos.2022.41636. Turkiye Parazitol Derg. 2022. PMID: 36444412 Review. English.
-
Epidemiological surveillance of Toxoplasma gondii in small ruminants in southern Spain.Prev Vet Med. 2020 Oct;183:105137. doi: 10.1016/j.prevetmed.2020.105137. Epub 2020 Sep 6. Prev Vet Med. 2020. PMID: 32950886
-
Seroprevalence of anti-Toxoplasma gondii antibodies in Egyptian sheep and goats.BMC Vet Res. 2018 Apr 2;14(1):120. doi: 10.1186/s12917-018-1440-1. BMC Vet Res. 2018. PMID: 29606142 Free PMC article.
Cited by
-
Nanospheres as the delivery vehicle: novel application of Toxoplasma gondii ribosomal protein S2 in PLGA and chitosan nanospheres against acute toxoplasmosis.Front Immunol. 2024 Oct 1;15:1475280. doi: 10.3389/fimmu.2024.1475280. eCollection 2024. Front Immunol. 2024. PMID: 39416787 Free PMC article.
-
Toxoplasma gondii infection: novel emerging therapeutic targets.Expert Opin Ther Targets. 2023 Apr-May;27(4-5):293-304. doi: 10.1080/14728222.2023.2217353. Epub 2023 May 24. Expert Opin Ther Targets. 2023. PMID: 37212443 Free PMC article. Review.
-
Nanoparticles as a Delivery System of Antigens for the Development of an Effective Vaccine against Toxoplasma gondii.Vaccines (Basel). 2023 Mar 25;11(4):733. doi: 10.3390/vaccines11040733. Vaccines (Basel). 2023. PMID: 37112645 Free PMC article. Review.
-
Coxiella burnetii and Co-Infections with Other Major Pathogens Causing Abortion in Small Ruminant Flocks in the Iberian Peninsula.Animals (Basel). 2022 Dec 7;12(24):3454. doi: 10.3390/ani12243454. Animals (Basel). 2022. PMID: 36552374 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
